Point72 Middle East Fze Revance Therapeutics, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$5.81 - $11.2 $419,743 - $809,144
72,245 Added 3464.99%
74,330 $653,000
Q3 2023

Nov 14, 2023
SELL
$11.47 - $25.07 $363,082 - $793,590
-31,655 Reduced 93.82%
2,085 $23,000
Q2 2023

Aug 14, 2023
BUY
$24.7 - $37.61 $833,378 - $1.27 Million
33,740 New
33,740 $853,000
Q4 2022

Feb 14, 2023
BUY
$18.32 - $30.66 $147,439 - $246,751
8,048 New
8,048 $0

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email